story of the week
Zoledronic Acid Every 12 Weeks Is Noninferior to Every 4 Weeks in Women With Breast Cancer Metastatic to Bone
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Continued Treatment Effect of Zoledronic Acid Dosing Every 12 vs 4 Weeks in Women With Breast Cancer Metastatic to Bone: The OPTIMIZE-2 Randomized Clinical Trial
JAMA Oncol 2017 Jan 26;[EPub Ahead of Print], GN Hortobagyi, C Van Poznak, WG Harker, WJ Gradishar, H Chew, SR Dakhil, BB Haley, N Sauter, R Mohanlal, M Zheng, A LiptonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.